Table 2 Pathological and surgical characteristics of patients with borderline ovarian tumors
From: Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
Frozen pathology records (n, %) | |
Benign | 30 (7.3) |
Borderline | 251 (61.6) |
At least borderline | 117 (28.7) |
Malignant | 9 (2.2) |
Accuracy of frozen pathology (n, %)* | |
Serous (n, %) | 288 (94) |
Mucinous (n, %) | 67 (80) |
Surgery Type (n, %) | |
Conservative | 345 (47.1) |
Radical | 388 (52.9) |
Conservative surgery type (n, %) | |
Unilateral cystectomy | 106 (30.7) |
Bilateral cystectomy | 20 (5.7) |
Cystectomy and contralateral ovarian biopsy | 7 (2.0) |
Unilateral salpingo-oopherectomy (USO) | 194 (56.2) |
USO and contralateral ovarian biopsy | 17 (4.9) |
Bilateral ovarian biopsy | 1 (0.2) |
Staging surgery (n, %) | |
None | 273 (37.2) |
Yes | |
Complete | 395 (53.9) |
Incomplete | 65 (8.9) |
Received postoperative chemotherapy | 101 (13.8) |
Appendectomy (n, %) | 289 (39.4) |
Appendectomy with serous histology | 159 |
Appendectomy with mucinous histology | 130 |
Appendicial involvement (n, %) | 23 (3.1) |
Appendicial involvement + mucinous type | 21 (2.8) |
Hysterectomy (n, %) | 436 (59.5) |
Median removed lymph nodes (n, range in numbers) | 25.7 ± 22.2 (2–173) |
Surgery type (n, %) | |
Laparascopy | 34 (4.6) |
Laparotomy | 699 (95.4) |
Recurrence (n, %) | 69 (9.4) |
Treatment after recurrence** | |
Surgery | 47 (6.4) |
Chemotherapy | 10 (1.4) |
Surgery + Chemotherapy | 12 (1.6) |
Recurrence (n, %)*** | |
Conservative group | 35 (10.5) |
Radical group | 34 (8.7) |
Recurrence (n, %)**** | |
Unstaging | 23 (8.4)*** |
Incomplete staging | 8 (12.3) |
Complete staging | 38 (9.6) |